IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML
Product details
Registration number: SIN15735P
Classification: Prescription Only
Active ingredients: Irinotecan 34.66 mg eqv Irinotecan Hydrochloride Trihydrate
Strength: 40 mg/vial
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: ACCORD HEALTHCARE PRIVATE LIMITED
ATC code: L01XX19
HSA approval date: 5 July 2019
Manufacturer(s): Intas Pharmaceuticals Limited
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15735P
Classification: Prescription Only
What active ingredients and strength are recorded for IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Irinotecan 34.66 mg eqv Irinotecan Hydrochloride Trihydrate
Strength: 40 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML?
According to the HSA dataset updated 7 August 2026:
Registrant: ACCORD HEALTHCARE PRIVATE LIMITED
Which manufacturers and countries are listed for IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Intas Pharmaceuticals Limited
Manufacturing country/countries: INDIA
Where can I look up IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15735P or the exact product name IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML. The general register link does not preselect this product.
What are the source dates for this IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this IRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15735P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)